122 related articles for article (PubMed ID: 30224918)
21. Comparison of differentiated thyroid cancer in children and adolescents (≤20 years) with young adults.
Alzahrani AS; Alkhafaji D; Tuli M; Al-Hindi H; Sadiq BB
Clin Endocrinol (Oxf); 2016 Apr; 84(4):571-7. PubMed ID: 26118454
[TBL] [Abstract][Full Text] [Related]
22. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow-up data.
Vural GU; Akkas BE; Ercakmak N; Basu S; Alavi A
Clin Nucl Med; 2012 Oct; 37(10):953-9. PubMed ID: 22899202
[TBL] [Abstract][Full Text] [Related]
24. Minimal extrathyroidal extension does not affect survival of well-differentiated thyroid cancer.
Al-Qurayshi Z; Shama MA; Randolph GW; Kandil E
Endocr Relat Cancer; 2017 May; 24(5):221-226. PubMed ID: 28249964
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.
Mercante G; Frasoldati A; Pedroni C; Formisano D; Renna L; Piana S; Gardini G; Valcavi R; Barbieri V
Thyroid; 2009 Jul; 19(7):707-16. PubMed ID: 19348581
[TBL] [Abstract][Full Text] [Related]
26. Innovative analysis of distant metastasis in differentiated thyroid cancer.
Chen D; Huang L; Chen S; Huang Y; Hu D; Zeng W; Wang M; Zhou W; Feng H; Wei W; Zhang C; Liu Z; Guo L
Oncol Lett; 2020 Mar; 19(3):1985-1992. PubMed ID: 32194693
[TBL] [Abstract][Full Text] [Related]
27. Correlation between body mass index and clinicopathological features of papillary thyroid microcarcinoma.
Liu Z; Maimaiti Y; Yu P; Xiong Y; Zeng W; Li X; Song H; Lu C; Xin Y; Zhou J; Zhang N; Ming J; Liu C; Shi W; Shi L; Li X; Nie X; Huang T
Int J Clin Exp Med; 2015; 8(9):16472-9. PubMed ID: 26629173
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors determining survival in differentiated thyroid cancer.
Gulcelik MA; Gulcelik NE; Kuru B; Camlibel M; Alagol H
J Surg Oncol; 2007 Dec; 96(7):598-604. PubMed ID: 17708543
[TBL] [Abstract][Full Text] [Related]
29. Recent Pregnancy Is Not Associated with High-Risk Pathological Features of Well-Differentiated Thyroid Cancer.
Chen AC; Livhits MJ; Du L; Wu JX; Kuo EJ; Yeh MW; Leung AM
Thyroid; 2018 Jan; 28(1):68-71. PubMed ID: 29160171
[TBL] [Abstract][Full Text] [Related]
30. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
31. Tumor aggressiveness risk factors in the differentiated thyroid carcinoma.
Lukas J; Hitnausova B; Jiskra J; Syrucek M
Bratisl Lek Listy; 2016; 117(2):91-3. PubMed ID: 26830039
[TBL] [Abstract][Full Text] [Related]
32. [The impact of patient and tumor related prognostic factors on survival in non-medullary differentiated thyroid cancer. A study of 125 cases].
Dănilă R; Popovici R; Grigorovici A; Ionescu L; Timofte D; Lefter L; Boiculesei LV; Ungureanu MC; Dragomir C
Rev Med Chir Soc Med Nat Iasi; 2007; 111(4):940-5. PubMed ID: 18389784
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer.
Imai H; Kuwako T; Kaira K; Masuda T; Miura Y; Seki K; Sakurai R; Utsugi M; Shimizu K; Sunaga N; Tomizawa Y; Ishihara S; Ishizuka T; Mogi A; Hisada T; Minato K; Takise A; Saito R; Yamada M
Cancer Chemother Pharmacol; 2017 Mar; 79(3):497-505. PubMed ID: 28168310
[TBL] [Abstract][Full Text] [Related]
34. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
35. Effect of Tumor Size on Risk of Metastatic Disease and Survival for Thyroid Cancer: Implications for Biopsy Guidelines.
Nguyen XV; Roy Choudhury K; Tessler FN; Hoang JK
Thyroid; 2018 Mar; 28(3):295-300. PubMed ID: 29373949
[TBL] [Abstract][Full Text] [Related]
36. Relationships between clinicopathological prognostic factors in papillary thyroid microcarcinoma: a refined analysis based on 428 cases.
Ciobanu Apostol D; Giuşcă SE; Căruntu ID; Lozneanu L; Andriescu EC; Moscalu M
Int J Clin Exp Pathol; 2017; 10(8):8944-8956. PubMed ID: 31966764
[TBL] [Abstract][Full Text] [Related]
37. Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes.
Balachandar S; La Quaglia M; Tuttle RM; Heller G; Ghossein RA; Sklar CA
Thyroid; 2016 Feb; 26(2):219-26. PubMed ID: 26854950
[TBL] [Abstract][Full Text] [Related]
38. Outcome Implication of Aortic Valve Area Normalized to Body Size in Asymptomatic Aortic Stenosis.
Tribouilloy C; Bohbot Y; Maréchaux S; Debry N; Delpierre Q; Peltier M; Diouf M; Slama M; Messika-Zeitoun D; Rusinaru D
Circ Cardiovasc Imaging; 2016 Nov; 9(11):. PubMed ID: 27903539
[TBL] [Abstract][Full Text] [Related]
39. [Relationship between body mass index and clinicopathological characteristics and prognosis of gastric cancer patients].
Han BL; Wang YM; Xue YW
Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):527-532. PubMed ID: 31357840
[No Abstract] [Full Text] [Related]
40. Notch1 Signaling Regulates the Aggressiveness of Differentiated Thyroid Cancer and Inhibits SERPINE1 Expression.
Yu XM; Jaskula-Sztul R; Georgen MR; Aburjania Z; Somnay YR; Leverson G; Sippel RS; Lloyd RV; Johnson BP; Chen H
Clin Cancer Res; 2016 Jul; 22(14):3582-92. PubMed ID: 26847059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
